OTC pharma and consumer healthcare products markets in Asia offer avenue of growth for pharma manufacturers. Coupled with increasing health and wellness awareness, economic growth and increasing consumer self-care by expanding choice and availability of OTC products. Asia’s OTC market is expected to continue growing in the years to come.
IBC’s 7th Annual OTC Pharma Asia is bringing key experts in OTC and VMS to address pertinent issues in Asia – the changing consumer buying behavior and consumer-centric marketing as well as product innovation strategies. The ultimate platform in Asia center staging top leaders in OTC drugs, global pharma manufacturers, retailers, FMCGs, government and regulatory bodies and pharmacies to highlight winning strategies in Asia how OTC and consumer healthcare medicines are accessible, affordable and trusted self-care solutions.
Area Vice President and General Manager, South East Asia, GSK Consumer Healthcare
Global Regulatory Affairs Associate Director, Tasly, China
Head of Pharmacovigilance China & Asia-Pacific, Bayer (South East Asia), Singapore
Director of Business Development and Product Development, Asia, Blackmores, Singapore
Regional Regulatory Director, APAC, MEA & LATAM, Mundipharma Consumer Healthcare, Singapore
Ruch De Silva
Commercial Director & Team Leader, Value Brands, Takeda, Singapore
International Marketing Partner
©2017, an Informa business